Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea flag South Korea · Delayed Price · Currency is KRW
107,400
+700 (0.66%)
Apr 29, 2026, 3:30 PM KST

Kolon TissueGene Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
9,100,6526,624,4131,847,594655,804612,433518,608
Upgrade
Market Cap Growth
156.92%258.54%181.73%7.08%18.09%5.93%
Upgrade
Enterprise Value
9,098,1246,582,6781,835,745610,221540,002508,454
Upgrade
Last Close Price
107400.0079600.0023250.009020.008890.008010.00
Upgrade
PS Ratio
1764.131284.12364.17176.9564.77129.55
Upgrade
PB Ratio
142.02103.3812.665.706.6913.42
Upgrade
P/TBV Ratio
142.41103.6712.685.716.7113.49
Upgrade
EV/Sales Ratio
-1276.03361.84164.6657.11127.01
Upgrade
Debt / Equity Ratio
1.241.240.120.060.080.19
Upgrade
Net Debt / Equity Ratio
-0.04-0.040.11-0.18-0.56-0.82
Upgrade
Net Debt / EBITDA Ratio
0.120.12-0.781.103.500.70
Upgrade
Net Debt / FCF Ratio
0.100.10-0.800.861.910.78
Upgrade
Asset Turnover
0.020.020.030.030.110.06
Upgrade
Inventory Turnover
59.0459.0457.4282.6419.3514.10
Upgrade
Quick Ratio
0.230.230.022.015.082.44
Upgrade
Current Ratio
0.240.240.102.245.442.69
Upgrade
Return on Equity (ROE)
-183.43%-183.43%-25.91%-16.69%-17.11%-109.20%
Upgrade
Return on Assets (ROA)
-4.32%-4.32%-7.70%-10.47%-11.90%-43.86%
Upgrade
Return on Capital Employed (ROCE)
-32.70%-32.70%-14.60%-17.00%-16.60%-104.10%
Upgrade
Earnings Yield
-2.12%-2.91%-1.83%-2.63%-1.82%-9.13%
Upgrade
FCF Yield
-0.28%-0.38%-1.11%-3.72%-4.38%-7.82%
Upgrade
Buyback Yield / Dilution
-6.78%-6.78%-7.32%-8.18%-8.25%-0.29%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.